Eastman Kodak Co acquire 18.7 pct equity Enzon Inc pharmaceutical company specialize protein therapy. Kodak secure worldwide marketing right Enzon's PEG enzyme treatment oxygen toxicity disorder hyperuricemia gout. The company acquire mln Enzon share 15 mln dlrs loan Enzon mln dlrs 30000 dlrs credit purchase price. Kodak drug cover marketing right initial stage U.S. Food Drug Administration approval process. It investment provide necessary capital complete FDA review process provide marketing outlet drugs. The drug PEG-superoxide disdmutase PEG-catalase oxygen toxicity disorder cause often-fatal tissue damage associate severe burn organ transplant heart attack trauma PEG-uricase treatment gout condition cause buildup level uric acid body. Reuter 